User profiles for K. Fragiadaki

Katerina Fragkiadaki

Associate Professor, Carnegie Mellon University
Verified email at cs.cmu.edu
Cited by 5182

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

A Arida, K Fragiadaki, E Giavri, PP Sfikakis - Seminars in arthritis and …, 2011 - Elsevier
OBJECTIVE:: Off-label use of anti-tumor necrosis factor (TNF) agents for Behçet's disease (BD)
is increasing. We evaluated published data on their efficacy and safety for patients with …

Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down‐regulation of the T cell costimulatory molecule CD40 ligand: an open …

…, S Lionaki, V Vigklis, KG Fragiadaki… - … : Official Journal of …, 2005 - Wiley Online Library
Objective Autoreactive B cells play a key role in tissue injury in systemic autoimmune
disease, and therefore a treatment resulting in B cell depletion could have benefit. This open‐label …

A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis

…, E Zampeli, K Fragiadaki, K Stamatelopoulos… - Atherosclerosis, 2011 - Elsevier
Interleukin (IL)-6 is a pleiotropic proinflammatory cytokine involved in the pathogenesis of
both atherosclerosis and rheumatoid arthritis. The role of the IL-6/IL-6 receptor pathway in the …

Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis

PP Sfikakis, VL Souliotis, KG Fragiadaki… - Clinical …, 2007 - Elsevier
B cell depletion may affect T cell activation and costimulation status in rituximab-treated
patients with SLE. We examined whether rituximab administration in patients with active lupus …

Predictors of morbidity and mortality in early systemic sclerosis: Long-term follow-up data from a single-centre inception cohort

…, VK Bournia, G Konstantonis, K Fragiadaki… - Autoimmunity …, 2018 - Elsevier
Objectives To determine predictors of morbidity and mortality in systemic sclerosis (SSc) in
a long-term follow-up of an inception cohort of early SSc patients. Methods We evaluated …

A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behçet's disease: a comparative 4-week study

…, E Delicha, S Masselos, K Fragiadaki… - …, 2011 - academic.oup.com
Objective. To compare a single infusion of the anti-TNF antibody infliximab vs CSs for acute
panuveitis attacks in Behçet’s disease (BD). Methods. A prospective, observational study of …

Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases

…, S Panopoulos, K Fragiadaki… - Annals of the …, 2022 - ard.bmj.com
Objective Τo report outcomes of breakthrough COVID-19 in comparison with COVID-19 in
unvaccinated patients with systemic rheumatic diseases (SRDs). Methods Patients with SRD …

Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic

…, A Arida, VK Bournia, K Fragiadaki… - Annals of the …, 2021 - ard.bmj.com
We read with great interest the preliminary German Society of Rheumatology recommendations
for the management of patients with autoimmune inflammatory rheumatic diseases (…

[PDF][PDF] Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis

E Terpos, K Fragiadaki, M Konsta… - Clinical and …, 2011 - clinexprheumatol.org
Objective A critical role of interleukin-6 (IL-6) in bone homeostasis has been suggested in
experimental studies. We examined whether inhibition of IL-6 receptor in patients with …

Recurrent network models for human dynamics

K Fragkiadaki, S Levine, P Felsen… - Proceedings of the IEEE …, 2015 - cv-foundation.org
… We represent K body joint locations as a set of KN ×N heat maps over the person’s
bounding box, that represent likelihood for each joint to appear in each of the N2 grid locations, …